Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis

N.L. Fewings, P.N. Gatt, F.C. McKay, G.P. Parnell, S.D. Schibeci, J. Edwards, M.A. Basuki, A. Goldinger, M.J. Fabis-Pedrini, A.G. Kermode, C.P. Manrique, J.L. McCauley, D. Nickles, S.E. Baranzini, T. Burke, S. Vucic, G.J. Stewart, D.R. Booth

Journal of Autoimmunity, Volume 78, March 2017, Pages 57–69


Classifying PML risk with disease modifying therapies

Joseph R. Berger

Multiple Sclerosis and Related Disorders, Volume 12, February 2017, Pages 59–63

Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic review

Rui Li, Xiaobo Sun, Yaqing Shu, Zhifeng Mao, Li Xiao, Wei Qiu, Zhengqi Lu, Xueqiang Hu

Multiple Sclerosis and Related Disorders, Volume 12, February 2017, Pages 23–28

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis

N.L. Fewings, P.N. Gatt, F.C. McKay, G.P. Parnell, S.D. Schibeci, J. Edwards, M.A. Basuki, A. Goldinger, M.J. Fabis-Pedrini, A.G. Kermode, C.P. Manrique, J.L. McCauley, D. Nickles, S.E. Baranzini, T. Burke, S. Vucic, G.J. Stewart, D.R. Booth

Journal of Autoimmunity, Volume 78, March 2017, Pages 57–69

Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis

Katerine Panichi Zanin Ferreira, Sayonara R Oliveira, Ana Paula Kallaur, Damacio R Kaimen-Maciel, Marcell Alysson B Lozovoy, Elaine Regina Delicato de Almeida, Helena Kaminami Morimoto, Leda Mezzaroba, Isaias Dichi, Edna Maria Vissoci Reiche, Andréa Name

Journal of the Neurological Sciences, Volume 373, 15 February 2017, Pages 236–241

Search this site

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in MS research sign up to our e-alert.

Subscribe »

About the Editors

  • Prof Timothy Vartanian

    Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
  • Dr Claire S. Riley

    Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...
  • Dr Rebecca Farber

    Rebecca Farber, MD is an attending neurologist and assistant professor of neurology at the Neurological Institute, Columbia University, in New...

This online Resource Centre has been made possible by a donation from EMD Serono, Inc., a business of Merck KGaA, Darmstadt, Germany.

Note that EMD Serono, Inc., has no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein are subject to an independent editorial review.

The Grant for Multiple Sclerosis Innovation
supports promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients.  For full information and application details, please click here

Journal Editor's choice

Recommended by Prof. Brenda Banwell

Causes of death among persons with multiple sclerosis

Gary R. Cutter, Jeffrey Zimmerman, Amber R. Salter, et al.

Multiple Sclerosis and Related Disorders, September 2015, Vol 4 Issue 5